Cold calling in pharmaceuticals
Pharma buys on quality, continuity, and compliance, not price. A call that speaks to supply reliability and regulatory rigor earns the evaluation.
Why cold calling works here
Pharmaceuticals (APIs, excipients, contract manufacturing, packaging, services, distribution) sell into a highly regulated, quality-first environment. Cold calling works B2B — reaching procurement, QA, medical, or pharmacy buyers — because supply continuity and regulatory compliance are existential: a supplier that fails an audit or causes a stockout of a critical drug is a serious problem. Lead with quality credentials, supply security, and regulatory track record, respect strict promotional rules, and target qualification and audit, not a quick sale.
Pains you can lever
- Supply continuity risk on critical products with single sourcing
- Suppliers failing quality audits or regulatory requirements
- Long lead times and shortages on key APIs or components
- Compliance and documentation gaps (GMP, serialization, traceability)
- Price and margin pressure from generics and tenders
How to open the call
Lead with supply security and quality: 'On your critical products, are you single-sourced — and how exposed are you if that supplier hits a quality or capacity issue? We're GMP-qualified and I'd like to be evaluated as your second source, so a stockout never becomes a crisis.'
Objections you'll hear (and how to handle them)
We have qualified, approved suppliers.
Qualifying a new supplier takes months.
Send me your documentation.
What Tepio's AI brief surfaces here
Tepio's AI brief reads the company's site to infer their products, likely inputs, and regulatory profile — so you open on a specific supply-continuity or quality angle relevant to them, within strict pharma promotional rules.
Ready to call better?
Open your workspace and run your first Flash Call today. 14-day trial, no credit card.
Try free